The impact of metabolic changes in type 2 diabetes on bone turnover.
DOI:
https://doi.org/10.26641/2307-0404.2018.2.133953Ключевые слова:
diabetes mellitus, insulin, bone remodelingАннотация
This article carried out analyzes which helps to identify risk factors associated with bone metabolism changes, and to determine indicators that are informative in terms of predicting the risk of low-traumatic fractures observed in patients with type 2 diabetes mellitus. This study revealed some correlation between serum insulin level, bone metabolism markers and bone mass density determined at the lumbar DXA in patients with type 2 diabetes mellitus. This suggests that the presence of type 2 diabetes in anamnesis aggravated violation of disturbances of bone remodeling, thus contributing to the development of osteoporosis. The purpose of this study was to identify complex relationships between the mineral, organic component of bone and the risk of fractures under the influence of metabolic changes associated with type 2 diabetes. This study suggests that obesity and hyperinsulinemia can not be bone-protective factors, this is confirmed by the growing body of evidence that points to the importance of measuring bone remodeling markers in combination with bone mineral density in assessing and predicting the risk of fractures. Clarification of the role of insulin in assessing bone health remains a matter of debate.
Библиографические ссылки
Farr JN, Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone. 2016;82:28-34.
Kahn SE. The relative contributions of insulin resistance and β–cell dysfunction to the patophysiology of type 2 diabetes. Diabetologia. 2005;48:3-19.
Premaor MO, Comim FV, Compston JE. Obesity and fractures. Arq Bras Endocrinol Metabol. 2014;58:470-7.
Hewston P, Deshpande N. Falls and balance impairments in older adults with type 2 diabetes: thinking beyond diabetic peripheral neuropathy. Can. J.Diabetes. 2016;40:6-9.
Riddle RC, Clemens TL. Insulin, osteoblasts, and energy metabolism: why bone counts calories. J Clin Invest. 2014;124:1465-7.
Manavalan JS, et al. Circulating osteogenic precursor cells in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2012;97:3240-50.
Pramojanee SN, Phimphilai M, Chattipakorn N, Chattipakorn SC. Possible roles of insulin signaling in osteoblasts. Endocrine Research. 2014;39(4):144-51.
Bredella MA, Gill CM, Gerweck AV, Landa MG, Kumar V, Daley SM, et al. Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology. 2013;269:534-41.
Russell M, Mendes N, Miller KK, Rosen CJ, Lee H, Klibanski A, et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010;95:1247-55.
Starup-Linde J, Vestergaard P. Biochemical bone turnover markers in diabetes mellitus – a systematic review. Bone. 2016;82:69-78.
Загрузки
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
